PortfoliosLab logoPortfoliosLab logo
NGD vs. IMRX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NGD vs. IMRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in New Gold Inc. (NGD) and Immuneering Corporation (IMRX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


NGD

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

IMRX

1D
1.70%
1M
-22.12%
YTD
-36.32%
6M
-31.09%
1Y
113.78%
3Y*
-24.01%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NGD vs. IMRX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
NGD
New Gold Inc.
4.25%251.21%69.86%48.98%-34.67%-10.18%
IMRX
Immuneering Corporation
-36.32%199.09%-70.07%51.55%-70.01%-17.08%

Correlation

The correlation between NGD and IMRX is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Jul 30, 2021

0.08

Fundamentals

EPS

NGD:

$1.61

IMRX:

-$293.00

Total Revenue (TTM)

NGD:

$1.46B

IMRX:

$0.00

Gross Profit (TTM)

NGD:

$758.26M

IMRX:

-$698.89K

EBITDA (TTM)

NGD:

$1.19B

IMRX:

-$15.38B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NGD vs. IMRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NGD

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


IMRX
IMRX Risk / Return Rank: 7575
Overall Rank
IMRX Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
IMRX Sortino Ratio Rank: 7878
Sortino Ratio Rank
IMRX Omega Ratio Rank: 8181
Omega Ratio Rank
IMRX Calmar Ratio Rank: 7676
Calmar Ratio Rank
IMRX Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NGD vs. IMRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for New Gold Inc. (NGD) and Immuneering Corporation (IMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NGDIMRXDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.29

Calmar ratioReturn relative to maximum drawdown

1.98

Martin ratioReturn relative to average drawdown

3.30

NGD vs. IMRX - Sharpe Ratio Comparison


Loading charts...

Drawdowns

NGD vs. IMRX - Drawdown Comparison


Loading charts...

Drawdown Indicators


NGDIMRXDifference

Max Drawdown

Largest peak-to-trough decline

-96.86%

Max Drawdown (1Y)

Largest decline over 1 year

-57.67%

Max Drawdown (3Y)

Largest decline over 3 years

-90.98%

Current Drawdown

Current decline from peak

-87.24%

Average Drawdown

Average peak-to-trough decline

-77.61%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.56%

Volatility

NGD vs. IMRX - Volatility Comparison


Loading charts...

Volatility by Period


NGDIMRXDifference

Volatility (1M)

Calculated over the trailing 1-month period

33.75%

Volatility (6M)

Calculated over the trailing 6-month period

79.00%

Volatility (1Y)

Calculated over the trailing 1-year period

124.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

114.45%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

114.45%

Dividends

NGD vs. IMRX - Dividend Comparison

Neither NGD nor IMRX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NGD vs. IMRX - Financials Comparison

This section allows you to compare key financial metrics between New Gold Inc. and Immuneering Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M20222023202420252026
496.10M
0
(NGD) Total Revenue
(IMRX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NGD and IMRX have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for NGD and IMRX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer